Literature DB >> 12554609

Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?

K Bakken1, A S Landheim, P Vaglum.   

Abstract

AIMS: This study evaluated the primary/secondary distinction among substance misusers according to comorbid mental disorders.
METHODS: A consecutive sample (n = 287) of DSM-IV substance dependents from public treatment facilities in two counties in Norway were assessed by the Composite International Diagnostic Interview. According to the debut of the first independent mental disorder, patients were divided into primary substance use disorder (SUD) (17%), secondary SUD (76%) and SUD in the same year as the first mental disorder (7%).
RESULTS: A lifetime substance-independent mental disorder was found in 90%. Forty-two per cent had a combination of substance-independent and substance-induced mental disorders. Five per cent had substance-induced mental disorders only. Primary SUD patients comprised less women, and a lower number of substance-independent mental disorders. Secondary SUD patients had more major depression, phobic disorders and obsessive-compulsive disorder. There were no differences between primary SUD and secondary SUD regarding the number of substance-induced disorders or the pattern of substance misuse.
CONCLUSIONS: Clinical differences between primary and secondary SUD were small and do not support the distinction.

Entities:  

Mesh:

Year:  2003        PMID: 12554609     DOI: 10.1093/alcalc/agg012

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  8 in total

1.  Comorbid mental disorders in substance users from a single catchment area--a clinical study.

Authors:  Anne-Marit Langås; Ulrik F Malt; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2011-02-12       Impact factor: 3.630

2.  Effects of major depression on crack use and arrests among women in drug court.

Authors:  Jennifer E Johnson; Catina C O'Leary; Catherine W Striley; Arbi Ben Abdallah; Susan Bradford; Linda B Cottler
Journal:  Addiction       Date:  2011-04-07       Impact factor: 6.526

3.  Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders.

Authors:  Daniel E Falk; Hsiao-Ye Yi; Michael E Hilton
Journal:  Drug Alcohol Depend       Date:  2008-01-22       Impact factor: 4.492

4.  'You wouldn't do that to an animal, would you?' Ethical issues in managing pain in patients with substance dependence.

Authors:  Georgina Morley; Gillian M Chumbley; Emma V Briggs
Journal:  Br J Pain       Date:  2019-11-12

5.  Multicenter Observational/Exploratory Study Addressed to the Evaluation of the Effectiveness and Safety of Pharmacological Therapy in Opioid-Dependent Patients in Maintenance Therapy in Southern Italy.

Authors:  Fatima Maqoud; Giada Fabio; Nunzio Ciliero; Marina Antonacci; Francesca Mastrangelo; Giorgio Sammarruco; Roberto Cataldini; Gabriella Schirosi; Salvatore De Fazio; Domenico Tricarico
Journal:  Pharmaceutics       Date:  2022-02-21       Impact factor: 6.321

6.  'The Drugs Did For Me What I Couldn't Do For Myself': A Qualitative Exploration of the Relationship Between Mental Health and Amphetamine-Type Stimulant (ATS) Use.

Authors:  Liam Patrick Spencer; Michelle Addison; Hayley Alderson; William McGovern; Ruth McGovern; Eileen Kaner; Amy O'Donnell
Journal:  Subst Abuse       Date:  2021-12-06

7.  Quality of life, depression, anxiety and suicidal ideation among men who inject drugs in Delhi, India.

Authors:  Gregory Armstrong; Amenla Nuken; Luke Samson; Shalini Singh; Anthony F Jorm; Michelle Kermode
Journal:  BMC Psychiatry       Date:  2013-05-27       Impact factor: 3.630

8.  An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: the Combined Alcohol Social Phobia (CASP) trial protocol.

Authors:  Andrew J Baillie; Claudia Sannibale; Lexine A Stapinski; Maree Teesson; Ronald M Rapee; Paul S Haber
Journal:  BMC Psychiatry       Date:  2013-07-30       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.